Atlas Trials

A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

Clinical trial NCT02044874 · COMPLETED

Trial details

NCT number
NCT02044874
Sponsor
Arena Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2014-03-01
Primary completion
2014-11-01
Enrollment
603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.